Until recently, patients undergoing lens implant surgery received a monofocal, or single focus IOL.  Monofocal IOLs implanted in both eyes generally provide excelletn distance vision while patients often need spectacle correction for near and intermediate vision.  In the late 1990s, Advanced Medical Optics (AMO) introduced its first multifocal IOL designed to provide multiple points of focus, thereby dramatically reducing the need for bifocals or trifocal glasses after surgery.

Today, with its many optical design enhancements, AMO's second-generation ReZoom^TM  Multifocal IOL is providing patients with a full range of vision and greater independence from glasses or contact lenses than ever before.  Clinical studies show that 92% of those receiving the ReZoom^TM lens technology "never", or "only occassionally", need to wear glasses.